Jun Hui Liu
President bij Yunnan Oriental Anti-Aging Biotechnology Co. Ltd.
Vermogen: 115 M $ op 31-03-2024
Profiel
Jun Hui Liu is currently the President & Director at Yunnan Oriental Anti-Aging Biotechnology Co. Ltd.
He previously worked as a Director at Walvax Biotechnology Co., Ltd.
and as a Member-Supervisory Board at Beijing ChinaEquity Investment Co., Ltd.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 30-09-2023 | 54 161 648 ( 3.48% ) | 115 M $ | 31-03-2024 |
Actieve functies van Jun Hui Liu
| Bedrijven | Functie | Begin |
|---|---|---|
| Yunnan Oriental Anti-Aging Biotechnology Co. Ltd. | President | 05-01-2012 |
Eerdere bekende functies van Jun Hui Liu
| Bedrijven | Functie | Einde |
|---|---|---|
Beijing ChinaEquity Investment Co., Ltd.
 Beijing ChinaEquity Investment Co., Ltd. Investment ManagersFinance Beijing ChinaEquity Investment Co. Ltd. operates as a private equity and venture capital firm, which engages in early, later stage, high growth, mergers and acquisitions investments. It invests in wide range of industries, including TMT, high-end consumer & retail, clean energy and healthcare. The company was founded by Chao Yong Wang on May 17,1999 and is headquartered in Beijing, China. | Director/Board Member | - |
| WALVAX BIOTECHNOLOGY CO., LTD. | Director/Board Member | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| WALVAX BIOTECHNOLOGY CO., LTD. | Health Technology |
 | Finance |
| Bedrijven in privébezit | 1 |
|---|---|
| Yunnan Oriental Anti-Aging Biotechnology Co. Ltd. |
